Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-07-24

FDA Approved: PLERIXAFOR — Original Application (Meitheal Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a generic version of plerixafor (Meitheal Pharmaceuticals) via an Original Application, enabling broader access for hematopoietic stem cell mobiliz…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Plerixafor (Plerixafor)

Snippet

ORIG AP for PLERIXAFOR (PLERIXAFOR)